Published in J Surg Res on November 10, 2009
Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am J Physiol Heart Circ Physiol (2007) 2.17
Effects of dietary sodium and genetic background on angiotensinogen and Renin in mouse. Hypertension (2002) 2.00
The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med (2005) 1.75
Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens (2012) 1.74
Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet (2004) 1.61
Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ Res (2009) 1.60
A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens (2005) 1.55
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
AGT genetic variation, plasma AGT, and blood pressure: An analysis of the Utah Genetic Reference Project pedigrees. Am J Hypertens (2010) 1.43
Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet (2001) 1.43
Marginal and internal fits of fixed dental prostheses zirconia retainers. Dent Mater (2008) 1.37
Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl (2004) 1.22
Renin and kallikrein in connecting tubule of mouse. Kidney Int (2003) 1.22
Power and replication in case-control studies. Am J Hypertens (2002) 1.14
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob Agents Chemother (2002) 1.09
Common variant of human NEDD4L activates a cryptic splice site to form a frameshifted transcript. J Hum Genet (2002) 1.09
Cryptococcus neoformans Infection in Patients With Cirrhosis, Including Liver Transplant Candidates. Medicine (Baltimore) (2004) 1.04
Expression and function of COX isoforms in renal medulla: evidence for regulation of salt sensitivity and blood pressure. Am J Physiol Renal Physiol (2005) 1.01
Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Transplantation (2003) 1.01
Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes. J Hypertens (2010) 0.97
Further evidence of a quantitative trait locus on chromosome 18 influencing postural change in systolic blood pressure: the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Am J Hypertens (2005) 0.94
Significance of urinary angiotensinogen in essential hypertension as a function of plasma renin and aldosterone status. J Hypertens (2005) 0.91
Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant (2002) 0.91
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation (2003) 0.89
Bleeding complications precipitated by unrecognized Gingko biloba use after liver transplantation. Transpl Int (2002) 0.87
Expression of angiotensinogen in proximal tubule as a function of glomerular filtration rate. Kidney Int (2004) 0.87
Genetic susceptibility to essential hypertension: insight from angiotensinogen. Hypertension (2007) 0.86
Haplotype association analysis of AGT variants with hypertension-related traits: the HyperGEN study. Hum Hered (2005) 0.86
Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease. Transplantation (2005) 0.86
Automated method for the isolation of collecting ducts. Am J Physiol Renal Physiol (2006) 0.85
Response to genetic manipulations of liver angiotensinogen in the physiological range. J Hum Genet (2008) 0.84
Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation (2002) 0.82
Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years. Transplantation (2005) 0.81
Transcriptional diversity and expression of NEDD4L gene in distal nephron. Biochem Biophys Res Commun (2005) 0.81
A human polymorphism affects NEDD4L subcellular targeting by leading to two isoforms that contain or lack a C2 domain. BMC Cell Biol (2009) 0.80
Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis. Transplantation (2002) 0.80
Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2011) 0.79
From genetics to mechanism of disease liability. Adv Genet (2008) 0.78
Physicians' attitude toward organ donation and transplantation in the USA. Clin Transplant (2013) 0.78
Large-scale search for genes predisposing to essential hypertension. Am J Hypertens (2003) 0.78
Absence of a catalytic water confers resistance to the neurotoxin gabaculine. FASEB J (2009) 0.78
Hypervolemia of pregnancy is not maintained in mice chronically overexpressing angiotensinogen. Am J Obstet Gynecol (2006) 0.77
Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients. Transplantation (2004) 0.77
Molecular cloning and functional analysis of a factor that binds to the proximal promoter of human angiotensinogen. J Hum Genet (2002) 0.77
Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience. Liver Transpl (2012) 0.75
Contribution of Sp1 to initiation of transcription of angiotensinogen. J Hum Genet (2002) 0.75
Perceived benefits of a transplant surgery experience to general surgery residency training. J Surg Educ (2011) 0.75
Towards control of aggregational behaviour of alpha-lactalbumin at acidic pH. J Fluoresc (2006) 0.75
Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients. J Clin Pharmacol (2002) 0.75
Bioinformatic Analyses of Whole-Genome Sequence Data in a Public Health Laboratory. Emerg Infect Dis (2017) 0.75
Organic mercury levels among the Yanomama of the Brazilian Amazon Basin. Ambio (2003) 0.75
[Human angiotensinogen gene and its implication in essential hypertension]. Nihon Rinsho (2004) 0.75